Taligen Therapeutics
Latest round
- Series B
Last raised
- Aug 2010
Total raised
- $79M
Investors
- 6
About Taligen Therapeutics
Founded in 2004 and headquartered in Cambridge, US, Taligen Therapeutics specializes in developing biotechnology solutions. The company was acquired by Alexion Pharmaceuticals, Inc. in January 2011 for USD 111 mn.Taligen Therapeutics specializes in providing innovative biotechnology solutions aimed at enhancing patient outcomes through advanced research and development. The company's core product offerings include comprehensive research modules tailored for teams of various sizes, enabling users to conduct basic and advanced biotechnology projects. Taligen’s services support researchers in developing groundbreaking therapies by facilitating quick onboarding and ensuring a high level of user satisfaction.Taligen Therapeutics operates on a subscription-based revenue model with tiered pricing plans that cater to different customer needs. The company’s pricing structure comprises three main service levels: Beginner at USD 35 per month for basic research and development tools; Expertise at USD 65 per month for comprehensive solutions including access to all research modules; and Expert at USD 125 per month for full access to all resources and 24/7 support.Taligen Therapeutics plans to leverage its recent acquisition by Alexion Pharmaceuticals to expand its research capabilities and introduce new product offerings that enhance therapeutic development. While specific details on upcoming product launches have yet to be disclosed, the company aims to broaden its market presence in Europe and North America by 2025.
Who invested in Taligen Therapeutics
6 investors across 4 rounds
See all investors in Taligen Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Taligen Therapeutics
Who invested in Taligen Therapeutics?
Taligen Therapeutics has 6 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Taligen Therapeutics raised?
Taligen Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Taligen Therapeutics last raise money?
Taligen Therapeutics's most recent round on record is a Series B, in Aug 2010.
What does Taligen Therapeutics do?
Founded in 2004 and headquartered in Cambridge, US, Taligen Therapeutics specializes in developing biotechnology solutions.
Where is Taligen Therapeutics headquartered?
Taligen Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Taligen Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Taligen Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Taligen Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.